Healthcare provider profile · identity verified

James Mitchell Waddy, M.D.

Family Practice · SUFFOLK, VA · NPI 1487603205

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	461	132
Amlodipine Besylate	Amlodipine Besylate	435	121
Gabapentin	Gabapentin	183	43
Losartan Potassium	Losartan Potassium	182	51
Hydrochlorothiazide	Hydrochlorothiazide	181	49
Levothyroxine Sodium	Levothyroxine Sodium	177	39
Albuterol Sulfate Hfa	Albuterol Sulfate	176	51
Metformin Hcl	Metformin Hcl	172	53
Tramadol Hcl	Tramadol Hcl	166	39
Lisinopril	Lisinopril	165	48
Omeprazole	Omeprazole	161	51
Trazodone Hcl	Trazodone Hcl	154	37
Simvastatin	Simvastatin	151	41
Rosuvastatin Calcium	Rosuvastatin Calcium	150	44
Montelukast Sodium	Montelukast Sodium	119	37
Pantoprazole Sodium	Pantoprazole Sodium	119	32
Furosemide	Furosemide	112	38
Metoprolol Succinate	Metoprolol Succinate	112	30
Carvedilol	Carvedilol	108	32
Pravastatin Sodium	Pravastatin Sodium	108	30
Allopurinol	Allopurinol	107	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	25
Sertraline Hcl	Sertraline Hcl	106	24
Fluticasone Propionate	Fluticasone Propionate	105	41
Tamsulosin Hcl	Tamsulosin Hcl	95	32
Meloxicam	Meloxicam	91	21
Duloxetine Hcl	Duloxetine Hcl	90	20
Alprazolam	Alprazolam	86	14
Ozempic	Semaglutide	86	15
Chlorthalidone	Chlorthalidone	78	24
Escitalopram Oxalate	Escitalopram Oxalate	76	19
Potassium Chloride	Potassium Chloride	76	14
Ezetimibe	Ezetimibe	72	21
Glipizide Er	Glipizide	67	17
Tizanidine Hcl	Tizanidine Hcl	65	22
Eliquis	Apixaban	64	18
Esomeprazole Magnesium	Esomeprazole Magnesium	62	15
Famotidine	Famotidine	62	22
Clopidogrel	Clopidogrel Bisulfate	59	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	19
Donepezil Hcl	Donepezil Hcl	58	12
Ibuprofen	Ibuprofen	57	17
Triamcinolone Acetonide	Triamcinolone Acetonide	56	34
Jardiance	Empagliflozin	53	suppressed
Hydralazine Hcl	Hydralazine Hcl	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	16
Oxybutynin Chloride Er	Oxybutynin Chloride	51	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	18
Metformin Hcl Er	Metformin Hcl	50	16
Spironolactone	Spironolactone	50	14
Synthroid	Levothyroxine Sodium	49	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	16
Celecoxib	Celecoxib	47	12
Citalopram Hbr	Citalopram Hydrobromide	47	12
Xarelto	Rivaroxaban	47	11
Lorazepam	Lorazepam	45	14
Januvia	Sitagliptin Phosphate	44	suppressed
Prednisone	Prednisone	44	26
Memantine Hcl	Memantine Hcl	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Telmisartan	Telmisartan	43	14
Diclofenac Sodium	Diclofenac Sodium	40	26
Atenolol	Atenolol	39	suppressed
Topiramate	Topiramate	39	suppressed
Nebivolol Hcl	Nebivolol Hcl	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	27
Diazepam	Diazepam	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	19
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Trulicity	Dulaglutide	33	11
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Azelastine Hcl	Azelastine Hcl	31	15
Ketoconazole	Ketoconazole	31	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Methylprednisolone	Methylprednisolone	31	23
Nifedipine Er	Nifedipine	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Finasteride	Finasteride	28	suppressed
Hydrocortisone	Hydrocortisone	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Acarbose	Acarbose	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	19
Naproxen	Naproxen	25	16
Sulindac	Sulindac	25	suppressed
Nitroglycerin	Nitroglycerin	24	13
Benazepril Hcl	Benazepril Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Colchicine	Colchicine	22	suppressed
Ibu	Ibuprofen	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Amoxicillin	Amoxicillin	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Desloratadine	Desloratadine	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	19	suppressed
Azithromycin	Azithromycin	18	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Felodipine Er	Felodipine	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ondansetron Odt	Ondansetron	17	14
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Risperidone	Risperidone	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Cephalexin	Cephalexin	16	12
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Multaq	Dronedarone Hcl	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Linzess	Linaclotide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Nystatin	Nystatin	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error